Iofetamine hydrochloride I 123 permits cerebral blood perfusion imaging with single photon emission computed tomography (SPECT). SPECT is more widely available than positron emission tomography, and complements anatomic visualization with X-ray computed tomography (CT) or magnetic resonance imaging. Iofetamine is an amphetamine analog that is rapidly taken up by the lungs, then redistributed principally to the liver and brain. The precise mechanism of localization has not been determined, but is believed to result from nonspecific receptor binding. Brain uptake peaks at 30 minutes postinjection and remains relatively constant through 60 minutes. The drug is metabolized and excreted in the urine, with negligible activity remaining at 48 hours. When compared with CT in stroke patients, visualization may be performed sooner after symptom onset and a larger zone of involvement may be evident with iofetamine. Localization of seizure foci and diagnosis of Alzheimer's disease may also be possible. As CT has revolutionized noninvasive imaging of brain anatomy, SPECT with iofetamine permits routine cerebral blood flow imaging.
Get full access to this article
View all access options for this article.
References
1.
WINCHELLHS, BALDWINRM, LINTH. Development of 1-123 labeled amines for brain studies: localization of 1-123 iodophenylalkyl amines in rat brain. J Nucl Med1980;21:940-6.
2.
HOSSMANKA, MIESG, PASCHENW, Multiparametric imaging of blood flow and metabolism after middle cerebral artery occlusion in cats. J Cereb Blood Flow Metab1985;5:97-107.
3.
SARGENTT, BRAUNG, BRAUNU, BUDINGERTF, SHULGINAT. Brain and retina uptake of a radio-iodine labeled psychotomimetic in dog and monkey. Commun Psychopharm1978;2:1-10.
4.
FULLERRW, HINESCW. Tissue levels of chloroamphetamines in rats and mice. J Pharm Sci1967;56:302-3.
5.
KUHLDE, BARRIOJR, HUANGSC, Quantifying local cere-bral blood flow by N-isopropyl-p-[123I]iodoamphetamine (IMP) tomography. J Nucl Med1982;25:196-203.
6.
HOLMANBL, HILLTC, MAGISTRETTIPL. Brain imaging with emission computed tomography and radiolabeled amines. Invest Radiol1982;17:206-15.
7.
WINCHELLHS, HORSTWD, BRAUNL, OLDENDORFWH, HATT-NERR, PARKERH. N-isopropyl-[123I]p-iodoamphetamine: single-pass brain uptake and washout; binding to brain synaptoso-mes; and localization in dog and monkey brain. J Nucl Med 1980;21:947-52.
8.
OBRENOVITCHTP, CLAYTONCB, STRONGAJ. A double-radio-nuclide autoradiographic method using N-isopropyl-iodoam-phetamine for sequential measurements of local cerebral blood now. J Cereb Blood Flow Metab1987;7:356-65.
9.
HOLMANBL, ZIMMERMANRE, SCHAPIROJR, KAPLANML, JONESAG, HILLTC. Biodistribution and dosimetry of N-iso-propyl-p-[123I]iodoamphetamine in the primate. J Nucl Med1983;24:922-31.
10.
HOSHIH, JINNOUCHIS, WATANABEK, UEDAT, KINOSHITAK, YAMAGUCHIT. Biodistribution of N-isopropyl-p-iodoamphet-amine in the rat brain. Nuklearmedizin1987;26:131-4.
FUJIKAWADG, DWYERBE, WASTERLAINCG. Preferential blood flow to brainstem during generalized seizures in the newborn marmoset monkey. Brain Res1986;397:61-72.
13.
MORETTIJL, CINOTTIL, CESAROP, Amines for brain tomoscintigraphy. Nucl Med Commun1987;8:581-95.
14.
BALDWINRM, WUJL. In vivo chemistry of iofetamine HCl iodine-123 (IMP). J Nucl Med1988;29:122-4.
15.
HILLTC, HOLMANBL, LOVETTR, Initial experience with SPECT (single-photon computerized tomography) of the brain using N-isopropyl 1-123 p-iodoamphetamine: concise communication. J Nucl Med1982;25:191-5.
16.
LEERG, HILLTC, HOLMANBL, CLOUSEME. N-isopropyl (1-123) p-iodoamphetamine brain scans with single-photon emission tomography: discordance with transmission computed tomography. Radiology1982;745:795-9.
17.
URENRF, MAGISTRETTIPL, ROYALHD, Single-photon emission computed tomography. A method of measuring cerebral blood flow in three dimensions (preliminary results of studies in patients with epilepsy and stroke). Med J Aust1983; 1:411-3.
HIGAT, TANAKAT, IKEKUBOK, KOMATSUT, TORIZUKAK.SPECT with N-isopropyl-p iodoamphetamine in occlusive cerebrovascular disease. Clin Nucl Med1986;11:855-9.
20.
DEFERG, MORETTIJL, CESAROP, SERGENTA, RAYNAUDC, DEGOSJD. Early and delayed SPECT using N-isopropyl p-iodoamphetamine iodine 123 in cerebral ischemia. A prognostic index for clinical recovery. Arch Neurol1987;44:715-8.
21.
LEERGL, HILLTC, HOLMANBL, ROYALHD, O'LEARYDH, CLOUSEME. Predictive value of perfusion defect size using N-isopropyl-(I-123)-p-iodoamphetamine emission tomography in acute stroke. J Neurosurg1984;61:449-52.
22.
RAYNAUDC, RANCURELG, SAMSONY, Pathophysiologic study of chronic infarcts with 1-123 isopropyl iodo-ampheta-mine (IMP): the importance of periinfarct area. Stroke1987; 18:21-9.
23.
HELLMANRS, COLLIERBD, TIKOFSKYRS, Comparison of single-photon emission computed tomography with [123I]iodoamphetamine and xenon-enhanced computed tomography for assessing regional cerebral blood flow. J Cereb Blood Flow Metab1986;6:747-55.
24.
GEMMELLHG, SHARPPF, EVANSNTS, BESSONJAO, LYALLD, SMITHFW. Single photon emission tomography with 123I-iso-propylamphetamine in Alzheimer's disease and multi-infarct dementia (letter). Lancet1984;2:1348.
25.
JAGUSTWj, BUDINGERTF, REEDBR. The diagnosis of dementia with single photon emission computed tomography. Arch Neurol1987;44:258-62.
26.
COHENMB, GRAHAMLS, LAKER, Diagnosis of Alzheimer's disease and multiple infarct dementia by tomographic imaging of iodine-123 IMP. J Nucl Med1986;27:769-74.
27.
DEROUESNEC, RANCURELG, LE PONCIN LAFITTEM, RAPINJR, LASSENNA. Variability of cerebral blood flow defects in Alzheimer's disease on 123iodo-isopropyl-amphetamine and single photon emission tomography (letter). Lancet1985;7:1282.
28.
JOHNSONKA, MUELLERST, WALSHETM, ENGLISHRJ, HOLMANBL. Cerebral perfusion imaging in Alzheimer's disease. Use of single photon emission computed tomography and iofetamine hydrochloride I 123. Arch Neurol1987;44:165-8.
29.
Package insert. Spectamine (iofetamine). Paramus, NJ: Medi-Physics, December 1987.
30.
POLCYNRE, KOEPPER, HUTCHINSG, NICKLESRJ, GATLEYSJ, ROWEB. Hypercapnia and cerebral blood flow: an approach to testing perfusion reserve (abstract). J Nucl Med1984;25:P110.
31.
BURTRW, REDDYRV, MOCKBM, WELLMANHN, SCHAUWECKERDS, WITTR. Acetazolamide enhancement of HIPDM brain flow distribution imaging. J Nucl Med1986; 27:1627-31.
32.
JARRETTF, POLCYNR, LEVINA, MCCORMICKD.The use of hypercapnea in the study of regional cerebral blood flow abnormalities with 133Xe. J Surg Res1982;52:104-9.
33.
ELLPA, HOCKNELLJML, JARRITTPH, A 99Tcm-labelled radiotracer for the investigation of cerebral vascular disease. Nucl Med Commun1985;6:437-41.
34.
HOLMESRA, CHAPLINSB, ROYSTONKG, Cerebral uptake and retention of 99Tcm-hexamethylpropyleneamine oxime (99Tcm-HM-PAO). Nucl Med Commun1985;6:443-7.
35.
SHARPP, SMITHFW, GEMMELLHG, Technetium-99m HM-PAO stereoisomers as potential agents for imaging regional cerebral blood flow: human volunteer studies. J Nucl Med1986;27:171-7.
36.
WADAM, ICHIYAY, KATSURAGIM, Scintigraphic visuali-zation of human malignant melanoma with N-isopropyl-p-[I-123]iodoamphetamine. Clin Nucl Med1985;70:415-7.
